NCT06367452View on ClinicalTrials.gov

Exploratory Pilot Study to Evaluate the Pharmacokinetic Profile of Magaldrate

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

January 15, 2024

Study Completion Date

March 30, 2024

Conditions
Healthy
Interventions
DRUG

Sodium alginate + sodium bicarbonate + magaldrate + simeticone

Take an oral suspension of 10 mL 30 minutes after the ingestion of a standardized breakfast

Trial Locations (1)

13087-567

CAEP, Campinas

All Listed Sponsors
lead

Tecnoquimicas

INDUSTRY

NCT06367452 - Exploratory Pilot Study to Evaluate the Pharmacokinetic Profile of Magaldrate | Biotech Hunter | Biotech Hunter